161 related articles for article (PubMed ID: 6208038)
21. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages.
Fernandez-Gomez R; Esteban S; Gomez-Corvera R; Zoulika K; Ouaissi A
J Immunol; 1998 Apr; 160(7):3471-9. PubMed ID: 9531308
[TBL] [Abstract][Full Text] [Related]
22. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites.
Marinho CR; Nuñez-Apaza LN; Martins-Santos R; Bastos KR; Bombeiro AL; Bucci DZ; Sardinha LR; Lima MR; Alvarez JM
Scand J Immunol; 2007; 66(2-3):297-308. PubMed ID: 17635807
[TBL] [Abstract][Full Text] [Related]
23. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
Abrahamsohn IA; Coffman RL
J Immunol; 1995 Oct; 155(8):3955-63. PubMed ID: 7561103
[TBL] [Abstract][Full Text] [Related]
24. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
Nickell SP; Sharma D
Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
[TBL] [Abstract][Full Text] [Related]
25. Abnormal IFN-gamma-dependent immunoproteasome modulation by Trypanosoma cruzi-infected macrophages.
Bergeron M; Blanchette J; Rouleau P; Olivier M
Parasite Immunol; 2008 May; 30(5):280-92. PubMed ID: 18312504
[TBL] [Abstract][Full Text] [Related]
26. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.
Nabors GS; Tarleton RL
J Immunol; 1991 May; 146(10):3591-8. PubMed ID: 1902857
[TBL] [Abstract][Full Text] [Related]
27. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.
Martin D; Tarleton R
Immunol Rev; 2004 Oct; 201():304-17. PubMed ID: 15361249
[TBL] [Abstract][Full Text] [Related]
28. Apoptotic lymphocytes treated with IgG from Trypanosoma cruzi infection increase TNF-alpha secretion and reduce parasite replication in macrophages.
Montalvão F; Almeida GM; Silva EM; Borges VM; Vasconcellos R; Takiya CM; Lopes MF; Nunes MP; DosReis GA
Eur J Immunol; 2010 Feb; 40(2):417-25. PubMed ID: 19950177
[TBL] [Abstract][Full Text] [Related]
29. Immune resistance to Trypanosoma cruzi: synergy of specific antibodies and recombinant interferon gamma in vivo.
Plata F; Garcia-Pons F; Wietzerbin J
Ann Inst Pasteur Immunol; 1987; 138(3):397-415. PubMed ID: 3115278
[TBL] [Abstract][Full Text] [Related]
30. Trypanosoma cruzi triggers an early type I IFN response in vivo at the site of intradermal infection.
Chessler AD; Unnikrishnan M; Bei AK; Daily JP; Burleigh BA
J Immunol; 2009 Feb; 182(4):2288-96. PubMed ID: 19201883
[TBL] [Abstract][Full Text] [Related]
31. Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages.
Camargo MM; Andrade AC; Almeida IC; Travassos LR; Gazzinelli RT
J Immunol; 1997 Dec; 159(12):6131-9. PubMed ID: 9550414
[TBL] [Abstract][Full Text] [Related]
32. Beta-interferon inhibits cell infection by Trypanosoma cruzi.
Kierszenbaum F; Sonnenfeld G
J Immunol; 1984 Feb; 132(2):905-8. PubMed ID: 6418814
[TBL] [Abstract][Full Text] [Related]
33. Proapoptotic activity of a Trypanosoma cruzi ceramide-containing glycolipid turned on in host macrophages by IFN-gamma.
Freire-de-Lima CG; Nunes MP; Corte-Real S; Soares MP; Previato JO; Mendonça-Previato L; DosReis GA
J Immunol; 1998 Nov; 161(9):4909-16. PubMed ID: 9794425
[TBL] [Abstract][Full Text] [Related]
34. Antigenic polymorphism of Trypanosoma cruzi: clonal analysis of trypomastigote surface antigens.
Plata F; Garcia Pons F; Eisen H
Eur J Immunol; 1984 May; 14(5):392-9. PubMed ID: 6373305
[TBL] [Abstract][Full Text] [Related]
35. Protected Trypanosoma cruzi infection in rats born to mothers receiving interferon-gamma during gestation is associated with a decreased intramacrophage parasite growth and preferential synthesis of specific IgG2b antibodies.
Didoli GL; Davila HO; Feldman S; di Masso R; Revelli SS; Bottasso OA
Int J Immunopharmacol; 2000 Jan; 22(1):45-55. PubMed ID: 10684988
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.
Silva JS; Morrissey PJ; Grabstein KH; Mohler KM; Anderson D; Reed SG
J Exp Med; 1992 Jan; 175(1):169-74. PubMed ID: 1730915
[TBL] [Abstract][Full Text] [Related]
37. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.
Pérez Brandán C; Mesías AC; Parodi C; Cimino RO; Pérez Brandán C; Diosque P; Basombrío MÁ
BMC Infect Dis; 2017 Nov; 17(1):732. PubMed ID: 29178839
[TBL] [Abstract][Full Text] [Related]
38. Agglutination of Trypanosoma cruzi in infected cells treated with serum from chronically infected mice.
Wendelken JL; Rowland EC
J Parasitol; 2009 Apr; 95(2):337-44. PubMed ID: 18922039
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).
Silva JS; Twardzik DR; Reed SG
J Exp Med; 1991 Sep; 174(3):539-45. PubMed ID: 1908509
[TBL] [Abstract][Full Text] [Related]
40. Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity.
Golden JM; Tarleton RL
Exp Parasitol; 1991 May; 72(4):391-402. PubMed ID: 1902795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
